(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Akerna Corp., Kubient, and Immuron Limited.

Rank Financial Asset Price Change Updated (EST)
1 Akerna Corp. (KERNW) 0.08 55.56% 2022-05-13 02:24:16
2 Kubient (KBNT) 1.00 34.48% 2022-05-13 01:23:13
3 Immuron Limited (IMRNW) 0.30 27.66% 2022-05-12 21:06:06
4 Molecular Data (MKD) 0.12 26.48% 2022-05-13 13:15:12
5 Beyond Meat (BYND) 31.07 23.88% 2022-05-13 14:53:22
6 Zai Lab (ZLAB) 33.19 22.61% 2022-05-13 14:55:20
7 Spectra Energy (SE) 75.34 22.6% 2022-05-13 14:54:40
8 IMAC Holdings (IMACW) 0.12 20% 2022-05-12 19:49:12
9 StoneCo (STNE) 8.69 19.63% 2022-05-13 14:55:45
10 MicroStrategy (MSTR) 204.77 19.62% 2022-05-13 14:57:58

The three most active and biggest losers today are Intellicheck, Stealth BioTherapeutics Corp., and Twitter.

Rank Financial Asset Price Change Updated (EST)
1 Intellicheck (IDN) 1.43 -26.29% 2022-05-12 19:08:06
2 Stealth BioTherapeutics Corp. (MITO) 0.22 -12.04% 2022-05-13 13:14:13
3 Twitter (TWTR) 40.74 -9.62% 2022-05-13 14:56:03
4 Luokung Technology Corp (LKCO) 0.43 -8.94% 2022-05-13 07:12:05
5 LiqTech International (LIQT) 0.92 -8.5% 2022-05-13 06:23:13
6 36Kr Holdings (KRKR) 0.70 -7.87% 2022-05-13 03:09:48
7 Leap Therapeutics (LPTX) 0.97 -7.3% 2022-05-13 08:23:15
8 Nautilus (NLS) 2.47 -6.72% 2022-05-13 14:45:24
9 Repro Med Systems (KRMD) 1.96 -6.67% 2022-05-13 03:10:06
10 LogicBio Therapeutics (LOGC) 0.38 -6.25% 2022-05-13 07:47:13

Most Active Winners today

1. Akerna Corp. (KERNW) – 55.56%

NASDAQ ended the session with Akerna Corp. jumping 55.56% to $0.08 on Friday while NASDAQ jumped 3.82% to $11,805.00.

Akerna Corp.’s last close was $0.08, 2.33% under its 52-week high of $0.08.

Akerna Corp.’s Stock Yearly Top and Bottom Value

Akerna Corp.’s stock is valued at $0.08 at 17:32 EST, below its 52-week high of $0.08 and way higher than its 52-week low of $0.07.

More news about Akerna Corp..

2. Kubient (KBNT) – 34.48%

Kubient, Inc. creates cloud-based software platforms for the digital advertising industry. Audience Cloud is a platform that allows real-time programmatic advertising trading. Its platform gives publishers and advertisers the opportunity to make use of machine learning in programmatic advertising space auctions. It was founded in New York in 2017.

NASDAQ ended the session with Kubient jumping 34.48% to $1.00 on Friday, after two consecutive sessions in a row of gains. NASDAQ jumped 3.82% to $11,805.00, following the last session’s upward trend on what was a very bullish trend trading session today.

Volume

Today’s last reported volume for Kubient is 827868 which is 1183.14% above its average volume of 64519.

Kubient’s last close was $1.00, 83.59% below its 52-week high of $6.08.

Kubient’s Sales

Kubient’s sales growth is a negative 38.9% for the ongoing quarter and 13% for the next. The company’s growth estimates for the current quarter and the next is a negative 91.7% and a negative 64.3%, respectively.

Kubient’s Revenue

Year-on-year quarterly revenue growth grew by 141.4%, now sitting on 3.03M for the twelve trailing months.

Kubient’s Stock Yearly Top and Bottom Value

Kubient’s stock is valued at $1.00 at 17:32 EST, way below its 52-week high of $6.08 and way above its 52-week low of $0.61.

Kubient’s Moving Average

Kubient’s value is way under its 50-day moving average of $1.51 and way below its 200-day moving average of $2.65.

More news about Kubient.

3. Immuron Limited (IMRNW) – 27.66%

NASDAQ ended the session with Immuron Limited rising 27.66% to $0.30 on Friday, after five sequential sessions in a row of losses. NASDAQ jumped 3.82% to $11,805.00, following the last session’s upward trend on what was a very positive trend exchanging session today.

Immuron Limited’s last close was $0.30, 25% below its 52-week high of $0.40.

Immuron Limited’s Stock Yearly Top and Bottom Value

Immuron Limited’s stock is valued at $0.30 at 17:32 EST, way below its 52-week high of $0.40 and way higher than its 52-week low of $0.24.

More news about Immuron Limited.

4. Molecular Data (MKD) – 26.48%

Through its subsidiaries, Molecular Data Inc. operates in China’s chemical ecommerce market. Through its integrated solutions, the company provides a technology-driven platform to connect participants across the entire chemical value chain. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites that are intended to solve pain points for participants in the traditional chemical industry. It offers its online solutions via molbase.com, molbase.cn and Moku Data Weixin accounts; Chemical Community app; as well other platforms. Shanghai is the headquarters of this company, which was established in 2013.

NASDAQ ended the session with Molecular Data jumping 26.48% to $0.12 on Friday, following the last session’s upward trend. NASDAQ jumped 3.82% to $11,805.00, following the last session’s upward trend on what was a very up trend exchanging session today.

Volume

Today’s last reported volume for Molecular Data is 15323100 which is 3.64% above its average volume of 14783800.

Molecular Data’s last close was $0.09, 91.33% below its 52-week high of $1.05.

Molecular Data’s Revenue

Year-on-year quarterly revenue growth declined by 67.1%, now sitting on 4.62B for the twelve trailing months.

Molecular Data’s Stock Yearly Top and Bottom Value

Molecular Data’s stock is valued at $0.12 at 17:32 EST, way under its 52-week high of $1.05 and way above its 52-week low of $0.07.

Molecular Data’s Moving Average

Molecular Data’s worth is way below its 50-day moving average of $0.16 and way under its 200-day moving average of $0.28.

More news about Molecular Data.

5. Beyond Meat (BYND) – 23.88%

Beyond Meat, Inc. is a food business that manufactures, markets, sells and distributes plant-based meat products both in the United States as well internationally. The Beyond Meat and Beyond Burger, Beyond Beef, Beyond Sausages, Beyond Breakfast Sausages, Beyond Chicken, Beyond Fried Chicken and Beyond Meatball trademarks are used. It sells products via grocery, convenience, club, club, and natural retailers channels. Savage River, Inc. was the company’s previous name. In September 2018, Beyond Meat, Inc. took over that title. Beyond Meat, Inc. was established in 2009. It is located in El Segundo, California.

NASDAQ ended the session with Beyond Meat jumping 23.88% to $31.07 on Friday, after five consecutive sessions in a row of losses. NASDAQ rose 3.82% to $11,805.00, following the last session’s upward trend on what was a very bullish trend exchanging session today.

Volume

Today’s last reported volume for Beyond Meat is 9315870 which is 163.31% above its average volume of 3537980.

Beyond Meat’s last close was $25.08, 84.35% under its 52-week high of $160.28.

Beyond Meat’s Sales

Beyond Meat’s sales growth is a negative 0.2% for the current quarter and 25.4% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 100% and a negative 35.7%, respectively.

Beyond Meat’s Revenue

Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 465.96M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Beyond Meat’s stock is considered to be overbought (>=80).

Beyond Meat’s Stock Yearly Top and Bottom Value

Beyond Meat’s stock is valued at $31.07 at 17:32 EST, way under its 52-week low of $35.41.

Beyond Meat’s Moving Average

Beyond Meat’s worth is way below its 50-day moving average of $43.67 and way under its 200-day moving average of $78.37.

More news about Beyond Meat.

6. Zai Lab (ZLAB) – 22.61%

Zai Lab Limited is a biopharmaceutical firm that focuses on developing and licensing therapeutics for medical use in China. Niraparib is an oral small-molecule poly ADPribose Polymerase 1/2 inhibitor that can be used to treat multiple solid tumors such as ovarian or other forms of lung cancer. Optune, which treats glioblastoma multifocale, is also available. Ripretinib is a switch inhibitor that can be used to treat KIT- and/or PDGFRa driven cancers. It also produces REGN1979, which treats diffuse large B cell lymphoma, and follicular Lymphoma. Margetuximab, an immuno-optimized monoclonal anti-HER2 antibody, for treatment of breast cancers and gastric cancers. INCMGA0012, a monoclonal investigational antibody, for treatment MSI-high endometrial carcinoma. Bemarituzumab is a monoclonal humanized antibody that can be used to treat gastric or gastroesophageal carcinomas. Omadacycline and Durlobactam are antibiotics for treating acinetobacter and baumannii bacteria infections. Zai Lab Limited is a licensee and has a collaboration agreement with Paratek Bermuda, Ltd., TESARO Inc., Entasis Therapeutics Holdings, Inc., Crescendo Biologics Ltd., Novocure Limited, MacroGenics Inc., Deciphera Pharmaceuticals, LLC, and Incyte Corporation. China’s Shanghai is the headquarters of this company, which was established in 2013.

NASDAQ ended the session with Zai Lab rising 22.61% to $33.19 on Friday while NASDAQ rose 3.82% to $11,805.00.

Volume

Today’s last reported volume for Zai Lab is 656598 which is 24.11% below its average volume of 865283.

Zai Lab’s last close was $29.78, 83.63% under its 52-week high of $181.92.

Zai Lab’s Revenue

Year-on-year quarterly revenue growth grew by 194.2%, now sitting on 115.23M for the twelve trailing months.

Zai Lab’s Stock Yearly Top and Bottom Value

Zai Lab’s stock is valued at $33.19 at 17:32 EST, way below its 52-week high of $181.92 and way higher than its 52-week low of $25.74.

Zai Lab’s Moving Average

Zai Lab’s value is way below its 50-day moving average of $41.90 and way under its 200-day moving average of $80.89.

More news about Zai Lab.

7. Spectra Energy (SE) – 22.6%

Sea Limited is involved in digital entertainment and e-commerce in Southeast Asia and Latin America. It also offers digital financial services businesses internationally. Garena is a digital entertainment platform that allows users to play online mobile games and eSports. It also provides access to entertainment content such as gameplay livestreaming and other social features such as chat and forums. Shopee is an e-commerce platform that operates on mobile devices. It offers integrated logistics and payment infrastructure as well as seller services. It also offers SeaMoney digital services to businesses and individuals, such as e-wallet, payment services AirPay and ShopeePayLater and ShopeePayLater; and processing services for Shopee. The former name of the company was Garena Interactive Holding Limited. In April 2017, Sea Limited took over that title. Sea Limited was established in Singapore in 2009.

NYSE ended the session with Spectra Energy jumping 22.6% to $75.34 on Friday, after four successive sessions in a row of losses. NYSE rose 2.19% to $15,257.36, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Spectra Energy is 15605400 which is 68.56% above its average volume of 9257940.

Spectra Energy’s last close was $91.04, 75.57% under its 52-week high of $372.70.

Spectra Energy’s Sales

Spectra Energy’s sales growth is 87.6% for the ongoing quarter and 69.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 33.3% and 52.4%, respectively.

Spectra Energy’s Revenue

Year-on-year quarterly revenue growth grew by 121.8%, now sitting on 8.3B for the twelve trailing months.

Spectra Energy’s Stock Yearly Top and Bottom Value

Spectra Energy’s stock is valued at $75.34 at 17:32 EST, below its 52-week low of $79.67.

Spectra Energy’s Moving Average

Spectra Energy’s worth is way below its 50-day moving average of $111.00 and way under its 200-day moving average of $234.18.

More news about Spectra Energy.

8. IMAC Holdings (IMACW) – 20%

NASDAQ ended the session with IMAC Holdings jumping 20% to $0.12 on Friday, after five consecutive sessions in a row of losses. NASDAQ rose 3.82% to $11,805.00, following the last session’s upward trend on what was a very positive trend exchanging session today.

IMAC Holdings’s last close was $0.12, 20% above its 52-week high of $0.10.

IMAC Holdings’s Stock Yearly Top and Bottom Value

IMAC Holdings’s stock is valued at $0.12 at 17:32 EST, way higher than its 52-week high of $0.10.

More news about IMAC Holdings.

9. StoneCo (STNE) – 19.63%

StoneCo Ltd. offers financial technology solutions for clients and integrate partners. It allows customers to transact electronically in Brazil through in-store and online channels. StoneCo Ltd. distributes their solutions through its proprietary Stone Hubs. These hubs offer local sales and services, and technology and solutions for digital merchants via sales personnel, technical vendors and sales staff. It also sells brick-and mortar and digital merchants with the help of a sales team. As of December 31, 2019, the company served approximately 495,100 clients primarily small-and-medium-sized businesses; and 116 integrated partners, such as global payment service providers, digital marketplaces, and integrated software vendors. It was established in 2012 in George Town in the Cayman Islands.

NASDAQ ended the session with StoneCo jumping 19.63% to $8.69 on Friday, after three sequential sessions in a row of gains. NASDAQ rose 3.82% to $11,805.00, following the last session’s upward trend on what was a very up trend trading session today.

Volume

Today’s last reported volume for StoneCo is 9611190 which is 2.5% above its average volume of 9376270.

StoneCo’s last close was $7.26, 89.79% under its 52-week high of $71.08.

The company’s growth estimates for the current quarter is a negative 40.9% and positive 41.7% for the next.

StoneCo’s Revenue

Year-on-year quarterly revenue growth grew by 56.1%, now sitting on 3.75B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

StoneCo’s stock is considered to be overbought (>=80).

StoneCo’s Stock Yearly Top and Bottom Value

StoneCo’s stock is valued at $8.69 at 17:32 EST, way below its 52-week high of $71.08 and above its 52-week low of $8.05.

StoneCo’s Moving Average

StoneCo’s value is way below its 50-day moving average of $10.88 and way under its 200-day moving average of $26.59.

More news about StoneCo.

10. MicroStrategy (MSTR) – 19.62%

MicroStrategy Incorporated offers enterprise analytics software and other services around the world. MicroStrategy 2020 is an enterprise platform that provides analytics across multiple devices. It allows analysts and data scientists seamless access to trust-governed data within their tool. MicroStrategy support is available to customers in order to help them achieve system availability, uptime and improve their overall user experience. This includes proactive product support and highly responsive technical troubleshooting. It also offers MicroStrategy Consulting, which provides architecture and implementation services that help customers quickly achieve results and maximize returns on their investment. It provides services via channel partners and enterprise sales. The company serves companies in a variety of sectors, such as retail, consulting and technology. It was established in Tysons Corner in Virginia in 1989.

NASDAQ ended the session with MicroStrategy jumping 19.62% to $204.77 on Friday, after two sequential sessions in a row of gains. NASDAQ rose 3.82% to $11,805.00, following the last session’s upward trend on what was a very bullish trend trading session today.

Volume

Today’s last reported volume for MicroStrategy is 2456310 which is 315.11% above its average volume of 591720.

MicroStrategy’s last close was $171.18, 80.8% under its 52-week high of $891.38.

MicroStrategy’s Sales

MicroStrategy’s sales growth is 1.4% for the current quarter and 15% for the next. The company’s growth estimates for the current quarter is 292.3% and a drop 11% for the next.

MicroStrategy’s Revenue

Year-on-year quarterly revenue growth grew by 0.5%, now sitting on 507.57M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

MicroStrategy’s stock is considered to be overbought (>=80).

MicroStrategy’s Stock Yearly Top and Bottom Value

MicroStrategy’s stock is valued at $204.77 at 17:32 EST, way below its 52-week low of $282.55.

MicroStrategy’s Moving Average

MicroStrategy’s worth is way below its 50-day moving average of $431.08 and way below its 200-day moving average of $568.23.

More news about MicroStrategy.

Most Active Losers Today

1. Intellicheck (IDN) – -26.29%

Intellicheck, Inc. is a technology company that develops, integrates, markets and sells identity authentication and threat identification solutions. These include products for law enforcement threat identification, retail fraud prevention, bank fraud prevention, mobile access control, security systems, and hand-held access control. The main market for the company’s services is in the United States. It offers identity products such as ID Check A – Retail which authenticates identity documents. ID Check A – Online which authenticates online users of identification documents. ID Check A – IAM which speeds up property management system check-ins and ID verification; ID Check PC which can be used to access the same features as ID Check PC for Windows based platforms. Age ID is a tablet or smartphone-based solution to prevent the sale of restricted products to minors. Defense ID is a fixed and mobile solution to threat identification, authentication and control of military bases and commercial buildings. The company serves the military and government markets. The original name of the company was Intellicheck Mobilisa, Inc., but it changed its name in May 2017 to Intellicheck, Inc. Intellicheck, Inc. was founded in 1994. It is located in Melville, New York.

NASDAQ ended the session with Intellicheck dropping 26.29% to $1.43 on Friday, after two consecutive sessions in a row of losses. NASDAQ jumped 3.82% to $11,805.00, following the last session’s upward trend on what was a very up trend exchanging session today.

Volume

Today’s last reported volume for Intellicheck is 590465 which is 458.78% above its average volume of 105670.

Intellicheck’s last close was $1.43, 85.23% below its 52-week high of $9.68.

Intellicheck’s Sales

Intellicheck’s sales growth is 20.2% for the current quarter and a decline by 18.5% for the next. The company’s growth estimates for the present quarter and the next is a negative 66.7% and a negative 75%, respectively.

Intellicheck’s Revenue

Year-on-year quarterly revenue growth grew by 26.8%, now sitting on 16.39M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Intellicheck’s stock is considered to be overbought (>=80).

Intellicheck’s Stock Yearly Top and Bottom Value

Intellicheck’s stock is valued at $1.43 at 17:32 EST, way under its 52-week high of $9.68 and higher than its 52-week low of $1.33.

Intellicheck’s Moving Average

Intellicheck’s value is way below its 50-day moving average of $2.49 and way under its 200-day moving average of $5.64.

More news about Intellicheck.

2. Stealth BioTherapeutics Corp. (MITO) – -12.04%

Stealth BioTherapeutics Corp is a biotech company at the clinical stage. It specializes in developing and marketing therapies to treat mitochondrial dysfunction. Elamipretide is the company’s leading product candidate. It is currently in phase 3 clinical trials to treat Barth Syndrome, phase 2/3 clinical trials for treatment of Duchenne Cardiomyopathy and phase 2a clinical study to treat Friedreich’s Ataxia. Phase 2a clinical trial is underway to treat dry age-related macular Degeneration. Phase 2 clinical trial is ongoing to treat Leber’s hereditary Optic Neuropathy. Phase 3 is for treatment of replisome Myopathies. SBT-20 is a product candidate for treating complications such as diabetes, renal disease, ocular disorders, Parkinson’s and Huntington’s diseases. SBT-550 can be used to treat rare neurological conditions. SBT-272, a peptidometic, targets mitochondria and stabilizes mitochondrial function in the face of oxidative stress. Stealth BioTherapeutics Corp, which was established in 2006, is located in George Town in the Cayman Islands.

NASDAQ ended the session with Stealth BioTherapeutics Corp. falling 12.04% to $0.22 on Friday while NASDAQ jumped 3.82% to $11,805.00.

Volume

Today’s last reported volume for Stealth BioTherapeutics Corp. is 4792520 which is 149.49% above its average volume of 1920850.

Stealth BioTherapeutics Corp.’s last close was $0.25, 88.1% under its 52-week high of $2.10.

Stealth BioTherapeutics Corp.’s Stock Yearly Top and Bottom Value

Stealth BioTherapeutics Corp.’s stock is valued at $0.22 at 17:32 EST, way below its 52-week high of $2.10 and way above its 52-week low of $0.18.

Stealth BioTherapeutics Corp.’s Moving Average

Stealth BioTherapeutics Corp.’s value is way under its 50-day moving average of $0.52 and way under its 200-day moving average of $0.90.

More news about Stealth BioTherapeutics Corp..

3. Twitter (TWTR) – -9.62%

Twitter, Inc. is a social media platform that allows people to express themselves and have conversations in real-time, both nationally and internationally. It offers a variety of products and services. These include Twitter, which allows users to create, consume, distribute and discover content. Periscope is a mobile app that allows you to live broadcast with other people. The company also offers promoted services and products such as promoted Twitters, promoted accounts and promoted trends. This allows advertisers to market their products and services. The company also offers tools and public APIs to developers that allow them to add their content to the platform and syndicate it across other properties. Developers can then enhance their websites and apps with Twitter content. It also offers subscription access to the public data feed of data partners. Twitter, Inc. was established in 2006 in San Francisco, California.

NYSE ended the session with Twitter falling 9.62% to $40.74 on Friday while NYSE rose 2.19% to $15,257.36.

Volume

Today’s last reported volume for Twitter is 86981500 which is 70.57% above its average volume of 50994200.

Twitter’s last close was $33.00, 55% below its 52-week high of $73.34.

News about Twitter today

  • Twitter stock price collapses on news Elon Musk putting deal on hold. According to today’s article on FXStreet, "Twitter is trading at $40, next the Nasdaq collapses 17%, which brings Twitter down to $33. ", "The irony of Elon Musk taking to Twitter to announce that his deal to take over the company is on hold is not lost on anyone. "
  • Tesla stock news and forecast: TSLA bounces as musk backs away from twitter deal. According to today’s article on FXStreet, "It does perhaps stop a large chunk of Tesla stock from being pledged as collateral for the Twitter deal, so that is behind the relief rally.", "The Twitter takeover saga rumbles on with Elon trying to reduce his reliance on Tesla stock as collateral. "
  • Elon Musk says twitter deal 'temporarily on hold' pending fake account details. According to today’s article on MarketWatch, "Shares of Twitter Inc. plunged 17.9% in premarket trading Friday, after , said the hold on the deal is "pending details supporting calculation that spam/fake accounts do indeed represent less than 5% of users." Twitter’s stock is on track to open at the lowest price seen during regular-session hours since March 17, which was before Musk first disclosed he had acquired a large stake in Twitter. "

Twitter’s Sales

Twitter’s sales growth is 22.5% for the current quarter and 24.6% for the next. The company’s growth estimates for the present quarter is a negative 7.9% and positive 12.5% for the next.

Twitter’s Revenue

Year-on-year quarterly revenue growth grew by 37.1%, now sitting on 4.8B for the twelve trailing months.

Twitter’s Stock Yearly Top and Bottom Value

Twitter’s stock is valued at $40.74 at 17:32 EST, way under its 52-week high of $73.34 and way above its 52-week low of $31.30.

Twitter’s Moving Average

Twitter’s worth is higher than its 50-day moving average of $40.49 and way under its 200-day moving average of $50.28.

Previous days news about Twitter

  • The fate of donald trump's twitter presence depends on Elon Musk: 'i would reverse the permanent ban'. According to Benzinga on Tuesday, 10 May, "For Twitter to deserve public trust, it must be politically neutral, which effectively means upsetting the far right and the far left equally"
  • Musk's twitter deal is no sure thing. According to The Wall Street Journal on Wednesday, 11 May, "Elon Musk’s agreement to buy Twitter for $54.20 a share is leaving a lot of money on the table for anybody willing to ride his coattails. "

More news about Twitter.

4. Luokung Technology Corp (LKCO) – -8.94%

Luokung Technology Corp. and its subsidiaries offer location-based services as well as mobile applications products to long-distance travelers in China’s People’s Republic of China. Luokuang is a mobile content distribution platform, which provides information, entertainment and travel services. The company also offers software development kits and application-programming interfaces, which provide spatial-temporal big data analysis and customized map to software and mobile application developers; and spatial temporal indexing cloud service, a data-level virtualization technology. It also offers the information SuperEngine, which includes the server engine. This allows spatial temporal big data to be stored, managed, and indexed on the server-side. The Web graphics engine supports the transmission and display of graphics images as well as edge computing and multi-terminal or cross-platform. The company also offers spatial temporal cloud platforms that offer cloud services. These include data storage, platform support, and data resource. It can also help users aggregate multiple-source spatial data and map services and Internet of Things streaming data. Luokung Technology Corp. and Jiangsu Dianyu Information Technology Co. Ltd. have formed a strategic partnership to increase mobile big data services for the 5G era. Beijing is the company’s headquarters.

NASDAQ ended the session with Luokung Technology Corp sliding 8.94% to $0.43 on Friday while NASDAQ jumped 3.82% to $11,805.00.

Volume

Today’s last reported volume for Luokung Technology Corp is 1817320 which is 9.6% above its average volume of 1658090.

Luokung Technology Corp’s last close was $0.43, 85.67% below its 52-week high of $3.00.

Luokung Technology Corp’s Revenue

Year-on-year quarterly revenue growth grew by 417.1%, now sitting on 48.78M for the twelve trailing months.

Luokung Technology Corp’s Stock Yearly Top and Bottom Value

Luokung Technology Corp’s stock is valued at $0.43 at 17:32 EST, way below its 52-week high of $3.00 and higher than its 52-week low of $0.39.

Luokung Technology Corp’s Moving Average

Luokung Technology Corp’s value is way under its 50-day moving average of $0.53 and way under its 200-day moving average of $0.87.

More news about Luokung Technology Corp.

5. LiqTech International (LIQT) – -8.5%

LiqTech International, Inc., is a clean tech company that designs, manufactures, markets, sells, and supports automated filtering systems, ceramic silicon carbide liquid application, and diesel particulate filters. It operates in North America, Canada, Europe, Asia, South America, Canada, Europe, Asia, the Middle East, and South America. Under the LiqTech and Provital brands, the company produces and sells liquid filtering membranes made of ceramic silicon carbide. These are used to filter produced water and pre-filtration of reverse Osmosis water. They also have industrial applications and can be used to produce clean water for swimming pools and spas. The company also sells diesel particulate filters to reduce exhaust emissions for customers in the authentic retrofit market and for original equipment manufacturers; as well as plastics which offer machined and welded parts for prepress, ultraviolet, and aquaculture markets. LiqTech International, Inc. is a distributor of its products to the industrial market. Blue Moose Media, Inc. was the company’s previous name. In October 2011, it changed its name from Blue Moose Media, Inc. to LiqTech International, Inc. LiqTech International, Inc. is an entity that was founded in 2004. Its headquarters are in Ballerup, Denmark.

NASDAQ ended the session with LiqTech International falling 8.5% to $0.92 on Friday, after five consecutive sessions in a row of losses. NASDAQ jumped 3.82% to $11,805.00, following the last session’s upward trend on what was a very positive trend exchanging session today.

Volume

Today’s last reported volume for LiqTech International is 648041 which is 147.07% above its average volume of 262281.

LiqTech International’s last close was $0.92, 88.7% below its 52-week high of $8.14.

LiqTech International’s Sales

LiqTech International’s sales growth is 54% for the present quarter and 104.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 47.1% and 63.6%, respectively.

LiqTech International’s Revenue

Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 16.22M for the twelve trailing months.

LiqTech International’s Stock Yearly Top and Bottom Value

LiqTech International’s stock is valued at $0.92 at 17:33 EST, way below its 52-week high of $8.14 and above its 52-week low of $0.90.

LiqTech International’s Moving Average

LiqTech International’s value is way under its 50-day moving average of $3.07 and way under its 200-day moving average of $4.91.

More news about LiqTech International.

6. 36Kr Holdings (KRKR) – -7.87%

36Kr Holdings Inc. provides content and services for new economic participants in China’s People’s Republic of China. The company creates and distributes a variety of content including reports that are insightful about companies, market updates and editorials in different industries such as healthcare, retail and consumer. Online advertising, enterprise value-added service, including integrated marketing and offline events as well consulting, are just a few of the services offered by the company. Subscription services can also be provided to institutional investors and individuals. 36Kr Holdings Inc. is located in Beijing in the People’s Republic of China.

NASDAQ ended the session with 36Kr Holdings sliding 7.87% to $0.70 on Friday while NASDAQ rose 3.82% to $11,805.00.

Volume

Today’s last reported volume for 36Kr Holdings is 46452 which is 62.37% below its average volume of 123468.

36Kr Holdings’s last close was $0.70, 74.82% under its 52-week high of $2.78.

36Kr Holdings’s Revenue

Year-on-year quarterly revenue growth declined by 31.2%, now sitting on 321.94M for the twelve trailing months.

36Kr Holdings’s Stock Yearly Top and Bottom Value

36Kr Holdings’s stock is valued at $0.70 at 17:33 EST, way below its 52-week high of $2.78 and way higher than its 52-week low of $0.50.

36Kr Holdings’s Moving Average

36Kr Holdings’s value is way below its 50-day moving average of $0.92 and way under its 200-day moving average of $1.31.

More news about 36Kr Holdings.

7. Leap Therapeutics (LPTX) – -7.3%

Leap Therapeutics, Inc., is a biopharmaceutical firm that acquires and develops treatments for cancer. DKN-01 is one of its leading clinical-stage programs. It inhibits Dickkopf related protein 1. The monoclonal antibody, which has been in clinical trials to treat esophagogastric, hepatobiliary, and prostate cancers, is currently being tested. The former name of the company was HealthCare Pharmaceuticals, Inc., but it changed its name to Leap Therapeutics, Inc., in November 2015. Leap Therapeutics, Inc. is an American company that was founded in 2011. Its headquarters are in Cambridge, Massachusetts.

NASDAQ ended the session with Leap Therapeutics falling 7.3% to $0.97 on Friday, after two consecutive sessions in a row of losses. NASDAQ rose 3.82% to $11,805.00, following the last session’s upward trend on what was a very up trend trading session today.

Volume

Today’s last reported volume for Leap Therapeutics is 1365030 which is 77.52% above its average volume of 768917.

Leap Therapeutics’s last close was $0.97, 76.67% under its 52-week high of $4.17.

Leap Therapeutics’s Sales

Leap Therapeutics’s sales growth is a negative 17.3% for the ongoing quarter and a decline by 76% for the next.

Leap Therapeutics’s Stock Yearly Top and Bottom Value

Leap Therapeutics’s stock is valued at $0.97 at 17:33 EST, way below its 52-week high of $4.17 and above its 52-week low of $0.92.

Leap Therapeutics’s Moving Average

Leap Therapeutics’s value is way under its 50-day moving average of $1.59 and way under its 200-day moving average of $2.23.

More news about Leap Therapeutics.

8. Nautilus (NLS) – -6.72%

NYSE ended the session with Nautilus falling 6.72% to $2.47 on Friday while NYSE jumped 2.19% to $15,257.36.

Volume

Today’s last reported volume for Nautilus is 1737030 which is 187.26% above its average volume of 604670.

Nautilus’s last close was $4.34, 76.65% below its 52-week high of $18.59.

Nautilus’s Sales

Nautilus’s sales growth is a negative 19.1% for the present quarter and a decline by 29.1% for the next. The company’s growth estimates for the present quarter and the next is a negative 151.5% and a negative 163.8%, respectively.

Nautilus’s Revenue

Year-on-year quarterly revenue growth declined by 11.2%, now sitting on 664.91M for the twelve trailing months.

Nautilus’s Stock Yearly Top and Bottom Value

Nautilus’s stock is valued at $2.47 at 17:33 EST, way under its 52-week low of $2.88.

Nautilus’s Moving Average

Nautilus’s worth is way under its 50-day moving average of $4.15 and way below its 200-day moving average of $7.89.

More news about Nautilus.

9. Repro Med Systems (KRMD) – -6.67%

Repro Med Systems, Inc., also known as KORU Medical Systems, develops, manufactures, markets, and sells portable medical devices primarily to the ambulatory market. It offers the mechanical infusion products FREEDOM60 syringe drivers, FreedomEdge syringe drivers, HIgHFlo subcutaneous safety needle sets and precision flow rate tubing. The company also offers education and training materials for patients and clinicians. It sells products via direct sales, distributors of medical devices and online. Repro Med Systems, Inc., was founded in 1980. It is located in Chester, New York.

NASDAQ ended the session with Repro Med Systems dropping 6.67% to $1.96 on Friday while NASDAQ jumped 3.82% to $11,805.00.

Volume

Today’s last reported volume for Repro Med Systems is 96748 which is 147.9% above its average volume of 39027.

Repro Med Systems’s last close was $1.96, 59.42% under its 52-week high of $4.83.

Repro Med Systems’s Sales

Repro Med Systems’s sales growth is 13.8% for the current quarter and 10.9% for the next. The company’s growth estimates for the current quarter and the next is a negative 133.3% and a negative 150%, respectively.

Repro Med Systems’s Revenue

Year-on-year quarterly revenue growth grew by 60%, now sitting on 23.49M for the twelve trailing months.

Repro Med Systems’s Stock Yearly Top and Bottom Value

Repro Med Systems’s stock is valued at $1.96 at 17:33 EST, under its 52-week low of $1.96.

Repro Med Systems’s Moving Average

Repro Med Systems’s value is way under its 50-day moving average of $2.84 and way under its 200-day moving average of $3.04.

More news about Repro Med Systems.

10. LogicBio Therapeutics (LOGC) – -6.25%

LogicBio Therapeutics, Inc., a gene editing company, focuses its efforts on the development of medicines that treat rare diseases for patients who have unmet medical needs using GeneRide technology platforms. GeneRide technology integrates corrective genes in a patient’s DNA to create a therapeutic effect. The lead product candidate of the company is LB-011, which is currently in Phase I/II clinical trial for treatment of methylmalonic acidsemia. The company has a partnership with Children’s Medical Research Institute for next-generation gene therapy and gene editing apps in the liver. It also has a collaboration agreement to Takeda Pharmaceutical Company Limited for next-generation gene therapy capsids and the editing candidate LB301 to treat Crigler-najjar Syndrome. The company has a strategic partnership and option agreement for CANbridge Pharmaceuticals Inc. Company was founded in 2014, and its headquarters are in Lexington Massachusetts.

NASDAQ ended the session with LogicBio Therapeutics sliding 6.25% to $0.38 on Friday while NASDAQ jumped 3.82% to $11,805.00.

Volume

Today’s last reported volume for LogicBio Therapeutics is 1033300 which is 21.46% below its average volume of 1315740.

LogicBio Therapeutics’s last close was $0.38, 92.68% under its 52-week high of $5.19.

LogicBio Therapeutics’s Sales

LogicBio Therapeutics’s sales growth is 167.5% for the current quarter and 95.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 54.5% and a negative 6.3%, respectively.

LogicBio Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 128.9%, now sitting on 3.92M for the twelve trailing months.

LogicBio Therapeutics’s Stock Yearly Top and Bottom Value

LogicBio Therapeutics’s stock is valued at $0.38 at 17:33 EST, way under its 52-week high of $5.19 and way higher than its 52-week low of $0.34.

LogicBio Therapeutics’s Moving Average

LogicBio Therapeutics’s value is way under its 50-day moving average of $0.63 and way below its 200-day moving average of $2.52.

More news about LogicBio Therapeutics.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here